omega-n-methylarginine has been researched along with Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, K; Fujii, K; Homma, H; Katane, M; Miyamoto, T; Nonaka-Hashida, S; Ozeki, Y; Saitoh, Y; Sekine, M; Shimoda, K; Tsunoda, M | 1 |
| Das, I; de Belleroche, J; Hirsch, SR; Khan, NS; Puri, BK; Sooranna, SR | 1 |
2 other study(ies) available for omega-n-methylarginine and Schizophrenia
| Article | Year |
|---|---|
Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Arginine; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Schizophrenia; Treatment Outcome; Young Adult | 2016 |
Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Blood Platelets; Brain; Calcium; Female; Humans; Kinetics; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Schizophrenia; Thrombin | 1995 |